Gabriel Etienne

16PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 15, 2026
Development and External Validation of a Transcriptome-Based Multivariable Prediction Model for Treatment-Free Remission in Chronic Myeloid Leukemia.

|Dec 15, 2025
Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Jorge E Cortes, Timothy P Hughes, Jianxiang Wang

|Nov 07, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

F Huguet, A Guerci-Bresler, G Roth-Guepin

|Mar 12, 2024
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.

Francois-Xavier Mahon, Markus Pfirrmann, Stéphanie Dulucq

|Feb 07, 2024
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.

Vincent Alcazer, Stéphane Morisset, Delphine Rea

|Apr 02, 2023
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.

Stéphanie Dulucq, Françoise Rigal-Huguet, Franck E Nicolini

Pageof 3

Frequent Collaborators

6 joint publications

Stéphanie Dulucq

5 joint publications

Delphine Réa

4 joint publications

Franck E Nicolini

3 joint publications

Emilie Klein